443 related articles for article (PubMed ID: 21889497)
1. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
2. Towards the design of combination therapy for the treatment of enterovirus infections.
Thibaut HJ; Leyssen P; Puerstinger G; Muigg A; Neyts J; De Palma AM
Antiviral Res; 2011 Jun; 90(3):213-7. PubMed ID: 21466823
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
4. The life cycle of non-polio enteroviruses and how to target it.
Baggen J; Thibaut HJ; Strating JRPM; van Kuppeveld FJM
Nat Rev Microbiol; 2018 Jun; 16(6):368-381. PubMed ID: 29626210
[TBL] [Abstract][Full Text] [Related]
5. Development of antiviral agents for enteroviruses.
Chen TC; Weng KF; Chang SC; Lin JY; Huang PN; Shih SR
J Antimicrob Chemother; 2008 Dec; 62(6):1169-73. PubMed ID: 18931391
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of substituted homoisoflavonoids on enteroviruses.
Tait S; Salvati AL; Desideri N; Fiore L
Antiviral Res; 2006 Dec; 72(3):252-5. PubMed ID: 16934879
[TBL] [Abstract][Full Text] [Related]
7. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.
Albulescu L; Strating JR; Thibaut HJ; van der Linden L; Shair MD; Neyts J; van Kuppeveld FJ
Antiviral Res; 2015 May; 117():110-4. PubMed ID: 25752737
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus infections with special reference to enterovirus 71.
Hsiung GD; Wang JR
J Microbiol Immunol Infect; 2000 Mar; 33(1):1-8. PubMed ID: 10806956
[TBL] [Abstract][Full Text] [Related]
9. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
[TBL] [Abstract][Full Text] [Related]
10. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
[TBL] [Abstract][Full Text] [Related]
11. Picornavirus non-structural proteins as targets for new anti-virals with broad activity.
Norder H; De Palma AM; Selisko B; Costenaro L; Papageorgiou N; Arnan C; Coutard B; Lantez V; De Lamballerie X; Baronti C; Solà M; Tan J; Neyts J; Canard B; Coll M; Gorbalenya AE; Hilgenfeld R
Antiviral Res; 2011 Mar; 89(3):204-18. PubMed ID: 21236302
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
Li C; Wang H; Shih SR; Chen TC; Li ML
Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
[TBL] [Abstract][Full Text] [Related]
13. Replication and Inhibitors of Enteroviruses and Parechoviruses.
van der Linden L; Wolthers KC; van Kuppeveld FJ
Viruses; 2015 Aug; 7(8):4529-62. PubMed ID: 26266417
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery in enteroviral infections.
Chen TC; Shih SR
Infect Disord Drug Targets; 2011 Jun; 11(3):337-45. PubMed ID: 21488833
[TBL] [Abstract][Full Text] [Related]
16. An antiviral small-interfering RNA simultaneously effective against the most prevalent enteroviruses causing acute hemorrhagic conjunctivitis.
Jun EJ; Won MA; Ahn J; Ko A; Moon H; Tchah H; Kim YK; Lee H
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):58-63. PubMed ID: 20739472
[TBL] [Abstract][Full Text] [Related]
17. Recent advances from studies on the role of structural proteins in enterovirus infection.
Wen X; Cheng A; Wang M; Jia R; Zhu D; Chen S; Liu M; Sun K; Yang Q; Wu Y; Chen X
Future Microbiol; 2015; 10(9):1529-42. PubMed ID: 26343779
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo.
Yang Y; Zhang L; Fan X; Qin C; Liu J
Bioorg Med Chem Lett; 2012 Mar; 22(6):2209-11. PubMed ID: 22342145
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
20. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
